Waverley Pharma Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was CAD 0.341927 million compared to CAD 0.382721 million a year ago. Net loss was CAD 0.121712 million compared to CAD 0.207248 million a year ago.
For the nine months, sales was CAD 1.07 million compared to CAD 1.29 million a year ago. Net loss was CAD 0.456744 million compared to CAD 0.528473 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.